A detailed history of Aqr Capital Management LLC transactions in Baxter International Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 932,911 shares of BAX stock, worth $35.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
932,911
Previous 808,020 15.46%
Holding current value
$35.4 Million
Previous $34.5 Million 9.64%
% of portfolio
0.05%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$32.87 - $43.55 $4.11 Million - $5.44 Million
124,891 Added 15.46%
932,911 $31.2 Million
Q1 2024

May 15, 2024

BUY
$37.88 - $43.77 $7.92 Million - $9.15 Million
208,969 Added 34.88%
808,020 $34.5 Million
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $5.6 Million - $6.87 Million
176,479 Added 41.76%
599,051 $23.2 Million
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $5.77 Million - $7.62 Million
-154,537 Reduced 26.78%
422,572 $15.9 Million
Q2 2023

Aug 14, 2023

BUY
$39.98 - $47.68 $345,827 - $412,432
8,650 Added 1.52%
577,109 $26.3 Million
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $18.1 Million - $25.3 Million
482,060 Added 557.95%
568,459 $23.1 Million
Q4 2022

Feb 14, 2023

SELL
$49.7 - $57.71 $3.86 Million - $4.48 Million
-77,705 Reduced 47.35%
86,399 $4.4 Million
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $2.57 Million - $3.18 Million
47,677 Added 40.95%
164,104 $8.84 Million
Q2 2022

Aug 15, 2022

SELL
$63.83 - $80.0 $9.32 Million - $11.7 Million
-146,070 Reduced 55.65%
116,427 $7.48 Million
Q1 2022

May 16, 2022

SELL
$76.85 - $89.45 $20.4 Million - $23.7 Million
-265,027 Reduced 50.24%
262,497 $20.4 Million
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $1.5 Million - $1.75 Million
-20,057 Reduced 3.66%
527,524 $45.3 Million
Q3 2021

Nov 15, 2021

SELL
$73.77 - $83.61 $8.23 Million - $9.33 Million
-111,617 Reduced 16.93%
547,581 $44 Million
Q2 2021

Aug 16, 2021

SELL
$80.5 - $88.01 $20.1 Million - $22 Million
-249,547 Reduced 27.46%
659,198 $53.1 Million
Q1 2021

May 17, 2021

SELL
$76.38 - $86.03 $12.3 Million - $13.9 Million
-161,031 Reduced 15.05%
908,745 $76.6 Million
Q4 2020

Feb 16, 2021

SELL
$75.39 - $82.36 $4.88 Million - $5.33 Million
-64,751 Reduced 5.71%
1,069,776 $85.1 Million
Q3 2020

Nov 16, 2020

SELL
$78.33 - $90.73 $26.9 Million - $31.2 Million
-343,480 Reduced 23.24%
1,134,527 $89.9 Million
Q2 2020

Aug 17, 2020

SELL
$78.66 - $94.14 $18.8 Million - $22.5 Million
-238,875 Reduced 13.91%
1,478,007 $125 Million
Q1 2020

May 15, 2020

SELL
$71.57 - $93.3 $39.2 Million - $51.1 Million
-547,986 Reduced 24.2%
1,716,882 $139 Million
Q4 2019

Feb 14, 2020

SELL
$76.7 - $88.45 $65.6 Million - $75.6 Million
-854,631 Reduced 27.4%
2,264,868 $189 Million
Q3 2019

Nov 14, 2019

SELL
$81.4 - $89.78 $41.3 Million - $45.6 Million
-507,641 Reduced 14.0%
3,119,499 $272 Million
Q2 2019

Aug 14, 2019

SELL
$73.44 - $82.41 $31.2 Million - $35 Million
-424,680 Reduced 10.48%
3,627,140 $296 Million
Q1 2019

May 14, 2019

SELL
$64.48 - $81.31 $68.3 Million - $86.1 Million
-1,059,137 Reduced 20.72%
4,051,820 $327 Million
Q4 2018

Feb 14, 2019

SELL
$61.45 - $77.8 $96.8 Million - $123 Million
-1,575,377 Reduced 23.56%
5,110,957 $336 Million
Q3 2018

Nov 15, 2018

SELL
$70.71 - $77.75 $7.19 Million - $7.9 Million
-101,613 Reduced 1.5%
6,686,334 $515 Million
Q2 2018

Aug 14, 2018

BUY
$63.43 - $75.41 $83.4 Million - $99.1 Million
1,314,437 Added 24.01%
6,787,947 $502 Million
Q1 2018

May 15, 2018

SELL
$62.56 - $72.26 $34.5 Million - $39.8 Million
-550,964 Reduced 9.15%
5,473,510 $356 Million
Q4 2017

Feb 14, 2018

BUY
$61.45 - $66.05 $15.3 Million - $16.4 Million
248,934 Added 4.31%
6,024,474 $389 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $344 Million - $373 Million
5,775,540
5,775,540 $362 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.1B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.